AdvaMed cautions FDA against unnecessary changes to 510(k) process

06/13/2013 | MassDevice.com (Boston)

An FDA proposal to increase its oversight of 510(k) medical device modifications has received pushback from AdvaMed, which warned the new rules could lead to a greater number of 510(k) submissions without doing much to benefit patient safety. The current process has proven to be successful in maintaining timely review and patient safety, and "it is unclear that there is a real problem that needs to be solved," AdvaMed said in a white paper. The FDA is scheduled to hold a public meeting today to discuss possible changes.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC